Education
About Us
Working with TipRanks
Follow Us
VanEck Biotech ETF (DE:VEFU)
BERLIN:VEFU
VEFU Stock Chart & Stats
Day’s Range― - ―
52-Week Range€139.16 - €163.54
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$391.85M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.23
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Dec 23, 2024Dividend Yield0.84%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$179.25Price Target Upside17.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering398
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
10.91% Other Institutional Investors
89.09% Public Companies and
Individual Investors
VEFU FAQ
What was VanEck Biotech ETF’s price range in the past 12 months?
VanEck Biotech ETF lowest stock price was €139.16 and its highest was €163.54 in the past 12 months.
What is VanEck Biotech ETF’s market cap?
VanEck Biotech ETF’s market cap is $391.85M.
When is VanEck Biotech ETF’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VanEck Biotech ETF’s earnings last quarter?
Currently, no data Available
Is VanEck Biotech ETF overvalued?
According to Wall Street analysts VanEck Biotech ETF’s price is currently Undervalued.
Does VanEck Biotech ETF pay dividends?
VanEck Biotech ETF pays a Annually dividend of €1.097 which represents an annual dividend yield of 0.84%. See more information on VanEck Biotech ETF dividends here
What is VanEck Biotech ETF’s EPS estimate?
VanEck Biotech ETF’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VanEck Biotech ETF have?
Currently, no data Available
What happened to VanEck Biotech ETF’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VanEck Biotech ETF?
Currently, no hedge funds are holding shares in DE:VEFU
VanEck Biotech ETF Stock Smart Score
Company Description
VanEck Biotech ETF
The VanEck Biotech ETF (BBH) is a targeted investment vehicle designed for those looking to capitalize on the rapid advancements and growth potential within the biotechnology sector, a dynamic niche within the broader health care industry. This ETF is meticulously curated, focusing exclusively on companies at the forefront of biotech innovation, including those involved in the development of new drug therapies, cutting-edge medical technologies, and revolutionary genetic research. By investing in BBH, investors gain exposure to a diversified portfolio of leading biotech firms, from established industry giants to pioneering startups. This positions the ETF as an attractive option for those seeking to participate in the transformative potential of biotechnology, which is driven by scientific breakthroughs and increasing demand for innovative health solutions. The VanEck Biotech ETF not only offers a strategic entry point into the health care sector but also provides an opportunity to benefit from the sector's unique growth trajectory and resilience in the face of global health challenges.